Latest papers

More than a prolactinoma.

Prolactinoma can be associated with gynecomastia.

Management of pituitary macroprolactinoma in a 27-year-old male patient from Taiwan.

Etiology, functional status and short term outcome of patients with pituitary lesions. An experience from a developing country.

[Pituitary tumors].

[Recent trends in the pathophysiology and treatment of pituitary adenomas].

Mammary tumor phenotypes in wild-type aging female FVB/N mice with pituitary prolactinomas.

Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.

Cabergoline resistance in pediatric prolactinomas.

Low-dose cabergoline causing valvular heart disease in a patient treated for prolactinoma.

Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.

Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?

Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions.

[Macroprolactinoma revealed by an exophthalmos].

Pathological gambling and hypersexuality in cabergoline-treated prolactinoma.

[Treatment strategy of pituitary invasive prolactinomas].

Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.

[Tumoral pituitary apoplexy and cocaine consumption]

[Prolactinoma].

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas.